spacer
home > epc > autumn 2008 > market epowers
PUBLICATIONS
European Pharmaceutical Contractor

Market ePowers

The biopharmaceutical industry is ideally situated to take advantage of the power of electronic marketing. Pharma companies will reap the rewards of developing highly effective, robust and scaleable electronic marketing programmes designed to meet today’s challenges.

These hurdles include:

  • Escalating competition for innovation
  • Promotion of new drugs or other products as soon as they are out of R&D
  • The rapid spread of globalisation requiring immediate international marketing efforts
  • Continually changing regulatory mandates that necessitate nimble response
  • Growing pressure to demonstrate financial performance despite finite or shrinking budgets

Whether a biotech or pharma business is in start-up mode, building demand or working toward an exit strategy, electronic marketing can play a central role in educating the worldwide market about pharmaceutical breakthroughs, establishing brand awareness, driving qualified leads, creating customer loyalty and increasing company valuation.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
With more than 17 years of communications experience, Margaret Osborn brings clients a wealth of brand development, strategic planning, and traditional and electronic marketing expertise. As Vice President of Synergy Marketing Group Inc, based in Indianapolis, Indiana, she specialises in marketing for high-tech, scientific and industrial B2B firms, including global companies in the life sciences, healthcare, biotechnology and pharmaceutical sectors.
spacer
Margaret Osborn
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Innovative Micro-Infusion Pump for Gerresheimer Subsidiary Sensile Medical Developed and Successfully Launched for EVER Pharma

Düsseldorf/Olten, July 03, 2019 – Developed specially by Sensile Medical for EVER Pharma under the brand name D-mine®, this wearable microinfusion pump recently received European CE certification and has already been launched in several European countries. The compact, patient-friendly infusion pump is used for the continuous subcutaneous administration of drugs to treat Parkinson’s disease. The first micro pump from Gerresheimer subsidiary Sensile Medical to be available on the market, it gives Parkinson’s patients greater independence in their day-today lives.
More info >>

White Papers

Characterisation of Biopharmaceutical Proteins

Reading Scientific Services Ltd (RSSL)

Over the next five years it is anticipated that there is going to be an explosion in the numbers of biosimilar products coming to market as patents expire. Consequently, in line with regulatory guidance, there will be a commensurate need to provide full characterisation of such biopharmaceuticals. The purpose of this article is to describe the array of the more common techniques used in biopharmaceutical characterisation (typically of protein or polypeptide). For full characterisation of a protein, the protein�s primary, secondary and tertiary structure as well as its physiochemical properties should be assessed.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement